Scaling Parenteral Drug Delivery: Why Next-Gen Biologics Demand a Specialized Device CDMO
As biopharmaceutical pipelines shift toward self-administered biologics, high-concentration formulations, and GLP-1 biosimilars, the boundary between drug product and drug delivery device has disappeared.
At MayMag Biologics, we bridge the gap between complex formulation physics and commercial-scale device manufacturing.
Core Device Capabilities & Engineering Solutions
1. Custom Pen Injector Device Developer
Off-the-shelf injection systems rarely accommodate the unique viscosity profiles and dosing precision required by novel biologic compounds. As a Custom Pen Injector Device Developer, MayMag Biologics customizes multi-dose and single-dose pen platforms tailored to your exact payload, volume limits, and patient dexterity requirements.
2. High-Volume Autoinjector Supplier & Assembly
Scaling from clinical evaluation to global commercial supply demands rigorous automation and supply chain security.
3. Commercial-Scale Insulin Device Manufacturing
Navigating biosimilar markets requires low unit costs paired with zero-defect execution. Backed by domestic manufacturing facilities and ranked among top US producers, our Commercial-Scale Insulin Device Manufacturing capabilities ensure uninterrupted market supply for chronic disease management.
Advanced Technical Specifications
| Parameter | Capability Specification |
| Cleanroom Operations | ISO Class 7 & Class 8 certified environments with automated particle monitoring |
| Quality Management | ISO 13485:2016 certified quality framework |
| Primary Packaging Support | 1.0 mL to 5.0 mL Prefilled Syringes (PFS) & standard cartridges |
| Viscosity Thresholds | Engineered auto-injection mechanisms capable of delivering up to 50 cP |
| Regulatory Compliance | US FDA cGMP compliant, USP <797> & <800> aligned |
Integrated Cleanroom Assembly & Packaging
[ Primary Container (PFS/Cartridge) ] ──► [ ISO 13485 Cleanroom Assembly ] ──► [ Automated Device Integration ] ──► [ Commercial Packaging & Release ]
ISO 13485 Cleanroom Device Assembly Services
Contamination control is critical when manufacturing drug-device combination products.
Primary Packaging Prefilled Syringe Manufacturer
Choosing the right container closure system determines your drug product's long-term stability. As an integrated Primary Packaging Prefilled Syringe Manufacturer partner, we ensure seamless compatibility between glass/polymer barrels, elastomeric stoppers, needle shields, and outer autoinjector shells.
Meeting the Demand for High-Viscosity Biologics
High-Volume Autoinjector for Large-Volume Biologics
Monoclonal antibodies (mAbs) and subcutaneous biological formulations often require larger injection volumes ($>2.0\text{ mL}$) and higher concentration limits. Our High-Volume Autoinjector for Large-Volume Biologics platform delivers consistent spring-force dynamics and controlled delivery times, reducing patient discomfort while securing complete dose delivery.
Biopharmaceutical Parenteral Delivery Device Supplier
As a single-source Biopharmaceutical Parenteral Delivery Device Supplier, MayMag Biologics streamlines your commercial supply chain.
Ready to Accelerate Your Device Pipeline?
Whether you are launching a biosimilar pen injector or scaling a novel high-volume autoinjector platform, MayMag Biologics offers the infrastructure, certifications, and expertise required to bring your drug-device combination to market.
Email: mmb@maymagbiologics.com
Website:
maymagbiologics.com
Comments
Post a Comment